1-4 March 2018
Buenos Aires, Argentina
Em colaboração com o XVIII Congresso da Sociedade Argentina de Infectologia (SADI), este encontro abarcará todos os campos das doenças infecciosas, prestando atenção especial aos principais desafios da região, incluindo o zika, o dengue e outras infecções virales relacionadas, SIDA, tuberculose, pneumonia e infecções entéricas e parasitárias, com um programa de profissionais internacionais e da região.
DNDi é uma organização que coopera com o evento. Os membros da DNDi participam da cerimônia de abertura e de simpósios.
Más información en inglés:
Opening Ceremony
Date: Thursday, 1 March 2018
Time: 18:30 – 20:00
Long-Term Zika Complications
Vanessa Van der Linden Mota, Association for Assistance of Disabled Children, Brazil |
Advances and Challenges in the Treatment of Chagas Disease – a Global Perspective
Sergio Sosa-Estani, Head of Chagas, DNDi Latin America, Argentina |
Enteric Infections in Under Resourced Countries – From Research to Clinical Practice
Gagandeep Kang, Executive Director, Translational Health Science & Technology, India |
The Human Microbiome
David Relman, Thomas C. and Joan M. Merigan Professor in Medicine, Microbiology & Immunology, Stanford University, USA |
Emerging Infectious Diseases – The Next Pandemic
George Fu Gao, Professor and Director in CAS Key Laboratory of Pathogenic Microbiology and Immunology, Chinese Academy of Sciences, China |
Parallel Symposium
New Outbreaks of Cutaneous Leishmaniasis and Management
In collaboration with DNDi
Date: Friday, 2 March 2018
Time: 17:00 – 18:00
Venue: Libertador A
Cutaneous Leishmaniasis Outbreaks and Management
Oscar Salomón, Director, National Institute of Tropical Medicine, Argentina |
Cutaneous Leishmaniasis: Treatment Needs and Combination Therapies
Byron Arana, Head of Cutaneous Leishmaniasis, DNDi, Switzerland |
Parallel Symposium
Alternative Strategies to Deliver Affordable Treatment for Hepatitis C Patients
In collaboration with DNDi
Date: Saturday, 3 March 2018
Time: 15:15 – 16:45
Venue: Libertador B
HCV- Global Challenges
Marcelo Silva, Head of Hepatology and Liver Transplant Unit, Austral University Hospital, Argentina |
Affordable Treatment Approaches: Results of a Phase III Trial of a Sofosbuvir + Ravidasvir Combination
Isabelle Andrieux-Meyer, Paediatric HIV/HCV Team Leader, DNDi, Switzerland |
Addressing IP Barriers To The Elimination of HCV As A Public Health Problem in Latin America
Francisco Viegas Neves da Silva, Regional Policy Advocacy Consultant, DNDi Latin America, Brazil
|